These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15353897)

  • 1. A framework for classifying study designs to evaluate health care interventions.
    Reeves BC
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():13-7. PubMed ID: 15353897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for caution when evaluating health care interventions using non-randomised study designs.
    Reeves BC
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():40-5. PubMed ID: 15353902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for reporting non-randomised studies.
    Reeves BC; Gaus W
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():46-52. PubMed ID: 15353903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic studies: pitfalls in interpretation.
    Westhoff CL
    Dialogues Contracept; 1995; 4(5):5-6, 8. PubMed ID: 12288680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic reviews incorporating evidence from nonrandomized study designs: reasons for caution when estimating health effects.
    Reeves BC; van Binsbergen J; van Weel C
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S155-61. PubMed ID: 16052184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of subjects for hospital-based epidemiologic studies based on outward manifestations of disease.
    Nishioka SA; Gyorkos TW; Joseph L; Collet JP
    Clin Invest Med; 2001 Dec; 24(6):299-303. PubMed ID: 11767233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling bias in complex nursing intervention studies: a checklist.
    Campbell-Yeo M; Ranger M; Johnston C; Fergusson D
    Can J Nurs Res; 2009 Dec; 41(4):32-50. PubMed ID: 20191712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are we missing anything? Pursuing research on attrition.
    Marcellus L
    Can J Nurs Res; 2004 Sep; 36(3):82-98. PubMed ID: 15551664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between RDD telephone and ABS mail survey design: coverage, unit nonresponse, and measurement error.
    Peytchev A; Ridenhour J; Krotki K
    J Health Commun; 2010; 15 Suppl 3():117-34. PubMed ID: 21154088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observational studies: a review of study designs, challenges and strategies to reduce confounding.
    Lu CY
    Int J Clin Pract; 2009 May; 63(5):691-7. PubMed ID: 19392919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlated errors in biased surrogates: study designs and methods for measurement error correction.
    Spiegelman D; Zhao B; Kim J
    Stat Med; 2005 Jun; 24(11):1657-82. PubMed ID: 15736283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bias: a review of current understanding.
    Adebiyi AO
    Afr J Med Med Sci; 2010 Sep; 39(3):241-8. PubMed ID: 21416795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study designs in clinical research.
    Noordzij M; Dekker FW; Zoccali C; Jager KJ
    Nephron Clin Pract; 2009; 113(3):c218-21. PubMed ID: 19690439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When should case-only designs be used for safety monitoring of medical products?
    Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based study designs in molecular epidemiology.
    García-Closas M; Vermeulen R; Cox D; Lan Q; Caporaso NE; Rothman N
    IARC Sci Publ; 2011; (163):241-59. PubMed ID: 22997866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A framework for applying unfamiliar trial designs in studies of rare diseases.
    Gupta S; Faughnan ME; Tomlinson GA; Bayoumi AM
    J Clin Epidemiol; 2011 Oct; 64(10):1085-94. PubMed ID: 21530171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.
    Glanz JM; McClure DL; Xu S; Hambidge SJ; Lee M; Kolczak MS; Kleinman K; Mullooly JP; France EK
    J Clin Epidemiol; 2006 Aug; 59(8):808-18. PubMed ID: 16828674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-control design: an appropriate strategy for nursing research.
    Polivka BJ; Nickel JT
    Nurs Res; 1992; 41(4):250-3. PubMed ID: 1482502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive use and cardiovascular disease: is the relationship real or due to study bias?
    Katerndahl DA; Realini JP; Cohen PA
    J Fam Pract; 1992 Aug; 35(2):147-57. PubMed ID: 1386621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A framework for planning and critiquing medication compliance and persistence research using prospective study designs.
    Gwadry-Sridhar FH; Manias E; Zhang Y; Roy A; Yu-Isenberg K; Hughes DA; Nichol MB
    Clin Ther; 2009 Feb; 31(2):421-35. PubMed ID: 19302915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.